AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

$212.43
-0.42 (-0.20%)
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 25 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -68.9% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $212.43
Current
$212.43
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-77.6%
Low target
Base Case
$66.03
-68.9%
Avg target
Bull Case
$88.20
+-58.5%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$260.19
-18.4% from high
52-Week Low
$96.09
+121.1% from low
50-Day SMA
$171.07
+24.2% vs SMA
200-Day SMA
$131.37
+61.7% vs SMA
RSI (14)
51.8
Neutral
Target vs 52W High
$66.03
-74.6% vs high
Next Earnings Report
Aug 10, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.86
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +11.9%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +16.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.8%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +30.5%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +172.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +173.7%